Ford C C - OmicsDI

Show results for

Unknown (3020)
Proteomics (52)
Transcriptomics (35)
Genomics (9)
Metabolomics (7)
Models (1)

Organisms

Homo sapiens (49)
Mus musculus (8)
Arabidopsis thaliana (5)
Saccharomyces cerevisiae (3)
Arabidopsis halleri (3)
Drosophila melanogaster (3)
Candida albicans (3)
Rattus norvegicus (2)
Pan troglodytes (2)
Escherichia coli (2)
Ruditapes philippinarum (1)
Brassica juncea (1)
Zea mays (1)
Oryza sativa (1)
Vitis vinifera (1)
Caenorhabditis elegans (1)
Anneissia japonica (1)
Bacteria (1)
Chlamydomonas reinhardtii (1)
Danio rerio (1)
Ixodes scapularis (1)
Kluyveromyces marxianus DMKU3-1042 (1)
Macaca mulatta (1)
Perna canaliculus (1)
Pseudomonas [fluorescens] SBW25 (1)
Saccharomyces kudriavzevii ZP591 (1)
Spodoptera frugiperda (1)

Organisms

Ruditapes philippinarum (1)
Homo sapiens (1)

Repository

pride (49)
biostudies-arrayexpress (42)
MetaboLights (5)
MassIVE (3)
GNPS (2)
ENA (2)
BioModels (1)
EGA (1)

Tissue

Cell culture (20)
B cell (4)
Epithelial cell of prostate (4)
Prostate adenocarcinoma cell line (3)
Embryonic stem cell (2)
HeLa cell (2)
Rosette (2)
Whole body (2)
Whole membrane (2)
Blood (1)
Blood plasma (1)
Cell suspension culture (1)
Endothelium (1)
Floret (1)
Heart (1)
Leukocyte (1)
Melanocyte (1)
Microvascular endothelium (1)
Pancreas (1)
Permanent cell line cell (1)
Photosynthetic cell (1)
Regular cardiac myocyte (1)
Saliva-secreting gland (1)
Salivary gland (1)
Schwann cell (1)
Skin (1)
Stem (1)
Stem cell (1)
T cell (1)

Disease

Prostate carcinoma (3)
Wounds and Injuries (3)
Disease free (2)
Metastatic colorectal cancer (1)
T-cell acute lymphoblastic leukemia (1)
Normal (1)
Acute leukemia (1)
Breast cancer (1)
Propionic acidemia (1)
Prostate cancer (1)

Technology Type

Mass Spectrometry (49)
Shotgun proteomics (22)
Bottom-up proteomics (21)
Data-independent acquisition (19)
Mass spectrometry (4)
Affinity purification coupled with mass spectrometry proteomics (2)
Data-dependent acquisition (2)
Gel-based experiment (2)
NMR spectroscopy (1)
Chemical cross-linking coupled with mass spectrometry proteomics (1)
SRM/MRM (1)
SWATH MS (1)
Top-down proteomics (1)

Instrument Platform

Q Exactive (4)
NextSeq 500 (2)
SYNAPT G2-Si (2)
TSQ Altis (2)
Xevo G2 XS Tof (2)
Xevo G2-XS QTof (2)
Unix (1)
Illumina MiSeq (1)
Illumina HiSeq 1500 (1)
Illumina HiSeq 2500 (1)
LCMS-IT-TOF (1)
Orbitrap Fusion ETD (1)
Q Exactive Plus (1)
Liquid Chromatography MS - alternating - reverse phase (1)
Liquid Chromatography MS - negative - reverse phase (1)
Nuclear Magnetic Resonance (NMR) - (1)

Publication Date

2025 (19)
2023 (9)
2022 (8)
2016 (7)
2014 (7)
2012 (6)
2021 (6)
2015 (5)
2013 (5)
2008 (5)
2020 (4)
2019 (4)
2005 (3)
2024 (3)
2026 (3)
2017 (2)
2018 (2)
2011 (1)
2010 (1)
2004 (1)

CHEBI ID

CHEBI:17964 (3)
CHEBI:10072 (2)
CHEBI:111517 (2)
CHEBI:132948 (2)
CHEBI:132966 (2)
CHEBI:133148 (2)
CHEBI:133172 (2)
CHEBI:133181 (2)
CHEBI:133183 (2)
CHEBI:133217 (2)
CHEBI:133226 (2)
CHEBI:133460 (2)
CHEBI:133512 (2)
CHEBI:133532 (2)
CHEBI:133559 (2)
CHEBI:133562 (2)
CHEBI:133565 (2)
CHEBI:133568 (2)
CHEBI:138368 (2)
CHEBI:138529 (2)
CHEBI:141472 (2)
CHEBI:143243 (2)
CHEBI:15318 (2)
CHEBI:15354 (2)
CHEBI:15356 (2)
CHEBI:15428 (2)
CHEBI:15611 (2)
CHEBI:15676 (2)
CHEBI:15689 (2)
CHEBI:15710 (2)

Metabolite Name

1-methyl-4-imidazoleacetate (2)
1-methyladenosine (2)
1-methylhistamine (2)
1-methylnicotinamide (2)
2'-O-methyluridine (2)
2'-deoxyinosine (2)
2,3-dihydroxyisovalerate (2)
2-aminoadipate (2)
2-hydroxy-3-methylvalerate (2)
2-hydroxyadipate (2)
2-hydroxybutyrate/2-hydroxyisobutyrate (2)
2-hydroxydecanoate (2)
2-hydroxyglutarate (2)
2-oxoarginine* (2)
3'-AMP (2)
3-aminoisobutyrate (2)
3-hydroxy-2-ethylpropionate (2)
3-hydroxy-3-methylglutarate (2)
3-hydroxyhexanoate (2)
3-hydroxyisobutyrate (2)
3-hydroxypyridine sulfate (2)
3-indoxyl sulfate (2)
3-methylhistidine (2)
3-phosphoglycerate (2)
3-sulfo-L-alanine (2)
3-ureidopropionate (2)
4-guanidinobutanoate (2)
4-hydroxyglutamate (2)
4-imidazoleacetate (2)
5'- GMP (2)

IsPrivate

False (1)

First Public Date

2025 (1)
2015 (1)

Modelling Approach

Ordinary differential equation model (1)

Modification

2x(15)N labeled L-lysine (1)
4-tetrahydrothiazine-3-carboxylic acid (1)
4x(15)N labeled L-arginine (1)

Study type

Transcription profiling by array (24)
RNA-seq of coding RNA (7)
ChIP-seq (5)
Unknown experiment type (2)
Comparative genomic hybridization by array (1)
Methylation profiling by array (1)
Methylation profiling by high throughput sequencing (1)

Release Date

2022 (338)
2025 (323)
2021 (318)
2023 (289)
2024 (279)
2019 (218)
2020 (209)
2018 (179)
2016 (148)
2015 (141)
2017 (130)
2014 (94)
2012 (80)
2013 (61)
2011 (60)
2026 (58)
2010 (52)
2009 (32)
2008 (27)
2007 (9)
2005 (4)
2006 (4)
2003 (3)
2004 (2)
2002 (1)
2000 (1)
1998 (1)
1997 (1)

Lab affiliation

UCSD (15)
CRUK - Beatson Institute for Cancer Research - Switchback Rd, Bearsden, Glasgow G61 1BD - United Kingdom (3)
MOBILion Systems, Inc. (2)
Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal. (2)
1. ARC Centre of Excellence in Plant Cell Walls, School of BioSciences, The University of Melbourne, Melbourne, VIC 3010, Australia 2. Joint BioEnergy Institute, Lawrence Berkeley National Laboratory, Berkeley, CA 94702, USA (1)
1. School of Biosciences, The University of Melbourne, Melbourne, VIC 3010, Australia 2. Joint BioEnergy Institute and Biological Systems and Engineering Division, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA (1)
CRUK Beatson Institute, Switchback Road, Glasgow G61 1BD, UK. (1)
California State University Long Beach (1)
Department of Anatomy and Developmental Biology, Australian Regenerative Medicine Institute, Monash University, Australia (1)
Department of Chemical & Systems Biology, Stanford University (1)
Department of Chemistry and Biomolecular Science, Clarkson University, Potsdam, NY (1)
Department of Chemistry, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA (1)
Department of Human Genetics (1)
Department of Human Genetics University of Chicago (1)
Department of Human Genetics, University of Chicago, Chicago, Illinois, USA; Department of Medicine, University of Chicago, Chicago, Illinois, USA (1)
Department of Medical Oncology and Department of Molecular Cancer Research, Cancer Genomics Netherlands, University Medical Center Utrecht, Utrecht, the Netherlands (1)
Department of Microbiology and Immunology University of Maryland School of Medicine USA (1)
Department of Neurology, Henry Ford Health (1)
Dept. Molecular Microbiology John Innes Centre Norwich Research Park Norwich, UK (1)
Drummond Lab, Genetics, Genomics, and Systems Biology, University of Chicago (1)
Genetics, Genomics, and Systems Biology, The University of Chicago (1)
Head of The Steen-Laboratory, Director of Proteomics, Boston Children's Hospital, Harvard Medical School (1)
Karolinska Institutet, Department of Oncology-Pathology (OnkPat) (1)
MOBILion Systems, Inc (1)
Oerthbio (1)
Parker Institute for Cancer Immunotherapy, Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, South Pavilion Tower, Building 421, Rm 8-103 3400 Civic Center Blvd. Philadelphia, PA 19104-5157 (1)
Plant and Food Research Institute New Zealand (1)
School of Biosciences, Parkville, VIC 3010, Melbourne, Australia (1)
School of Comparative Animal and Biomedical Sciences University of Arizona Tucson, AZ USA (1)
University of Oxford (1)

Tags

xref:PubMed:40730797 (1)
xref:PubMed:25555813 (1)

Previous page
1 / 313
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 313
Next page

Sort by:

Relevance

Page size

Stimulation of Host Immune Defenses by a Small Molecule Protects C. elegans from Bacterial Infection

The nematode Caenorhabditis elegans offers currently untapped potential for carrying out high-throughput, live-animal screens of low molecular weight compound libraries to identify molecules that target a variety of cellular processes. We previously used a bacterial infection assay in C. elegans to...

ORGANISM(S): Caenorhabditis elegans

2012-04-13 | E-GEOD-37266 | biostudies-arrayexpress

Wedelolactone, an Anti-inflammatory Botanical, Interrupts c-Myc Oncogenic Signaling and Synergizes with Enzalutamide to Induce Apoptosis in Prostate Cancer Cells.

Not available

S-EPMC5096967 | biostudies-literature

Predicting diabetes mellitus using SMOTE and ensemble machine learning approach: The Henry Ford ExercIse Testing (FIT) project.

Not available

S-EPMC5524285 | biostudies-literature

The effect of ultraviolet C radiation against different N95 respirators inoculated with SARS-CoV-2.

Not available

S-EPMC7470719 | biostudies-literature

Genome-wide analysis of H3K56ac across C. albicans genome in hyphae-inducing conditions

In the present study, we investigated whether the acetylation of H3K56, known as relevant for C. albicans virulence, might affect the Candida-macrophages interaction. Therefore, by the mean of the non-specific Hst3 inhibitor nicotinamide (NAM), we evaluated whether the alteration of H3K56 acetylatio...

ORGANISM(S): Candida albicans

2024-07-30 | E-MTAB-13387 | biostudies-arrayexpress

Differentiation of the four major species of cinnamons (C. burmannii, C. verum, C. cassia, and C. loureiroi) using a flow injection mass spectrometric (FIMS) fingerprinting method.

Not available

S-EPMC3983393 | biostudies-literature

Uptake of hepatitis C screening, characteristics of patients tested, and intervention costs in the BEST-C study.

Not available

S-EPMC5582998 | biostudies-literature

RNF10 and RIOK3 Facilitate 40S Ribosomal Subunit Degradation upon 60S Biogenesis Disruption or Amino Acid Starvation [Fig. 1F, 2A-C, 3A-C, 6A, S1F, S2A, S3A-D]

Ribosome-associated quality control (RQC) pathways target ribosomes whose progression becomes impaired during various phases of the translation cycle. Ribosome ubiquitylation is a key RQC licensing step. Previous studies identified an initiation specific RQC branch (iRQC) that is activated when tran...

ORGANISM(S): Homo sapiens (Human)

2025-02-07 | PXD060355 | Pride

L-tartaric acid synthesis from vitamin C in higher plants.

Not available

S-EPMC1459401 | biostudies-literature

Safety profile of boceprevir and telaprevir in chronic hepatitis C: real world experience from HCV-TARGET.

Not available

S-EPMC4586075 | biostudies-literature

Previous page
1 / 313
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 313
Next page

Sort by:

Relevance

Page size

3125 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

IsPrivate

First Public Date

Modelling Approach

Modification

Study type

Release Date

Lab affiliation

Tags

OmicsDI is part of the ELIXIR infrastructure

Tweets